Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Lee, Sang Soo ^a   Jeong, Sook Hyang ^a   Byoun, Young Sang ^a   Chung, Seong Min ^a   Seong, Mun Hyuk ^a   Sohn, Hyung Rae ^a   Min, Bo young ^a   Jang, Eun Sun ^a   Kim, Jin Wook ^a   Park, Guan Jung ^a   Lee, Yoon Jin ^a   Lee, Kyoung Ho ^a   Ahn, Soyeon ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Alcohol; Hepatocellular carcinoma; Non alcoholic fatty liver disease; Prognosis; Visceral fat

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL ASSOCIATED HEPATOCELLULAR CARCINOMA; ARTICLE; CANCER STAGING; CHILD PUGH SCORE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOGENIC HEPATOCELLULAR CARCINOMA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA; HEPATITIS C; HEPATITIS C VIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA; HUMAN; INTRAABDOMINAL FAT; KOREA; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER SPLEEN DENSITY RATIO; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN; PREVALENCE; SPLEEN; TUMOR INVASION; ALCOHOLISM; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; COMPLICATION; FATTY LIVER; LIVER NEOPLASMS; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOLOGY;

AGED; ALCOHOLISM; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE;

EID: 84879826031     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-335     Document Type: Article

References (31)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
2. Song IH, Kim KS. Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol 2009, 15(Suppl 6):S50-S59. 10.3350/kjhep.2009.15.S6.S50, 20037280.
3. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37(5):1202-1219. 10.1053/jhep.2003.50193, 12717402.
4. Torres DM, Harrison SA. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 2012, 32(1):30-38.
5. Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn WK, Canbay A. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Canc 2011, 128(10):2436-2443.
6. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36(6):1349-1354.
7. Tokushige K, Hashimoto E, Horie Y, Taniai M, Higuchi S. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol 2011, 46(10):1230-1237. 10.1007/s00535-011-0431-9, 21748549.
8. Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2004, 40(4):578-584. 10.1016/j.jhep.2004.02.013, 15030972.
9. Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, Hisatomi A, Ozaki I, Yamamoto K, Kitajima Y, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 2006, 41(5):462-469. 10.1007/s00535-006-1790-5, 16799888.
10. Kobayashi M, Suzuki M, Ikeda H, Takahashi H, Matsumoto N, Maeyama S, Sase S, Iino S, Itoh F. Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. Hepatol Res 2009, 39(1):31-39. 10.1111/j.1872-034X.2008.00407.x, 18761681.
11. Korean Liver Cancer Study Group and National Cancer Center, Korea [Practice guidelines for management of hepatocellular carcinoma 2009]. Korean J Hepatol 2009, 15(3):391-423. http://www.e-cmh.org/journal/view.php?number=3525, Korean Liver Cancer Study Group and National Cancer Center, Korea.
12. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42(5):1208-1236. 10.1002/hep.20933, 16250051.
13. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 2002, 11(Suppl 8):S732-S737.
14. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010, 30(1):61-74. 10.1055/s-0030-1247133, 20175034.
15. Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010, 116(22):5336-5339. 10.1002/cncr.25537, 20665503.
16. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006, 21(1 Pt 1):138-143.
17. Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, Sung IK, Park CY, Sohn CI, Jeon WK, et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 2004, 19(6):694-698. 10.1111/j.1440-1746.2004.03362.x, 15151626.
18. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11(1):74-80. 10.1002/hep.1840110114, 2295475.
19. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010, 51(5):1820-1832. 10.1002/hep.23594, 20432259.
20. White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 2012, 10(12):1342-1359. e1342, 10.1016/j.cgh.2012.10.001, 23041539.
21. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123(1):134-140. 10.1053/gast.2002.34168, 12105842.
22. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003, 38(2):420-427. 10.1053/jhep.2003.50320, 12883486.
23. Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?. Hepatol Res 2012, 42(1):1-14. 10.1111/j.1872-034X.2011.00872.x, 21917086.
24. Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011, 9(5):428-433. quiz e450, 10.1016/j.cgh.2011.01.023, 21320639.
25. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37(6):1286-1292. 10.1053/jhep.2003.50229, 12774006.
26. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2012, 56(6):1384-1391. 10.1016/j.jhep.2011.10.027, 22326465.
27. Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, Hori M, Kim T, Durand F, Wakasa K, Monden M, et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 2007, 243(2):422-430. 10.1148/radiol.2432051244, 17356175.
28. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37(1):154-160. 10.1016/S0168-8278(02)00099-5, 12076877.
29. Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, Humar A, Marsh JW, Geller DA, Tsung A. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology 2012, 55(6):1809-1819. 10.1002/hep.25536, 22183968.
30. Takuma Y, Nouso K, Makino Y, Gotoh T, Toshikuni N, Morimoto Y, Shimomura H, Yamamoto H. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. J Gastroenterol Hepatol 2011, 26(9):1417-1424.
31. Tokushige K, Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Shiratori K. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C. J Gastroenterol 2010, 45(9):960-967. 10.1007/s00535-010-0237-1, 20376504.